Efficacy of cognitive behaviour therapy in generalized anxiety disorders: Results of a controlled clinical trial (Berlin CBT-GAD study)

Psychotherapy and Psychosomatics

Volumn 74, Issue 1, 2005, Pages 36-42

  Linden, M ^a,b,c   Zubraegel, D ^a   Baer, T ^a   Franke, U ^a   Schlattmann, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BfA Rehabilitation Centre   (Germany)

^c BfA Klinik Seehof   (Germany)

Author keywords

Cognitive behaviour therapy; Controlled clinical trial; Generalized anxiety disorders

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR; BEHAVIOR THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW UP; HAMILTON SCALE; HUMAN; LICENSING; MAJOR CLINICAL STUDY; MEDICAL PROFESSION; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGIST; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; STATE TRAIT ANXIETY INVENTORY; STATISTICAL SIGNIFICANCE; TRAINING;

ADULT; ANXIETY DISORDERS; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 11844300396     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082025     Document Type: Article

References (46)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, American Psychiatric Press, 1994.
2. Borkovec TD, Newman MG: Worry and generalized anxiety disorder; in Salkovskis PM (ed): Clinical Formulation and Treatment. Oxford, Elsevier, 1999, pp 439-459.
3. Dugas MJ: Generalized anxiety disorder publications: So where do we stand? J Anxiety Disord 2000;14:31-40.
4. Linden M, Maier W, Achberger M, Herr R, Helmchen H, Benkert O: Psychische Erkrankungen und ihre Behandlung in Allgemeinarztpraxen in Deutschland. Ergebnisse aus einer Studie der Weltgesundheitsorganisation (WHO). Nervenarzt 1996;67:205-215.
5. Carter RM, Wittchen HU, Pfister H, Kessler RC: One year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 2001;13:78-88.
6. Wittchen HU, Hoyer J: Generalized anxiety disorder: Nature and course. J Clin Psychiatry 2001;62(suppl 11):15-21.
7. Kessler RC, Keller MB, Wittchen HU: The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am 2001;24:19-39.
8. Brawman-Mintzer O, Lydiard RB: Generalized anxiety disorder: Issues in epidemiology. J Clin Psychiatry 1996;57(suppl 7):3-8.
9. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, Jarrell MP, Ballenger JC: Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry 1993;150:1216-1218.
10. Dyck IR, Phillips KA, Warshaw MG, Dolan RT, Shea MT, Stout RL, Massion AO, Zlotnick C, Keller MB: Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia. J Personal Disord 2001;15:60-71.
11. Rickels K, Downing R, Schweizer E, Hassman H: Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazadone, and diazepam. Arch Gen Psychiatry 1993;50:884-895.
12. Roerig JL: Diagnosis and management of generalized anxiety disorder. J Am Pharmacol Assoc 1999;39:811-821.
13. Ballenger JC: Current treatments of the anxiety disorders in adults. Biol Psychiatry 1999;46:1579-1594.
14. Rocca P, Fonzo V, Scott M, Zanalda E, Ravizza L: Paroxetine efficay in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997;95:444-450.
15. Davidson JRT, DuPont RL, Hedges D, Haskins JT: Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999;60:528-535.
16. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E: Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder. A 6-month randomized controlled trial. J Am Med Assoc 2000;283:3082-3090.
17. Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK: Paroxetine in the treatment of generalized anxiety disorder: Results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001;62:350-357.
18. Rickels K, Pollack MH, Sheehan DV, Haskins JT: Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorders. Am J Psychiatry 2000;157:968-974.
19. Hackett D: Venlafaxine XR in the treatment of anxiety. Acta Psychiatr Scand Suppl 2000;406:30-35.
20. Durham RC, Allan T: Psychological treatment of generalised anxiety disorder. A review of the clinical significance of results in outcome studies since 1980. Br J Psychiatry 1993;163:19-26.
21. Fisher PL, Durham RC: Recovery rates in generalized anxiety disorder following psychological therapy: An analysis of clinically significant change in the STAI-T across outcome studies since 1990. Psychol Med 1999;29:1425-1434.
22. Gould RA, Otto MW, Pollack MH, Yap L: Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behav Ther 1997;28:285-305.
23. Ruhmland M, Margraf J: Effektivität psychologischer Therapien von generalisierter Angststörung und sozialer Phobie: Meta-Analysen auf Störungsebene. Verhaltenstherapie 2001;11:27-40.
24. Borkovec TD, Ruscio AM: Psychotherapy for generalized anxiety disorder. J Clin Psychiatry 2001;62:37-42.
25. Butler G, Fennell M, Robson P, Gelder M: Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 1991;59:167-175.
26. Barlow DH, Rapee RM, Brown TA: Behavioral treatment of generalized anxiety disorder. Behav Ther 1992;23:551-570.
27. Borkovec TD, Costello E: Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 1993;61:611-619.
28. Durham RC, Murphy T, Allan T, Richard K, Trevling LR, Fenton GW: Cognitive therapy, analytic psychotherapy and anxiety management training for generalised anxiety disorder. Br J Psychiatry 1994;165:315-323.
29. Ladouceur R, Dugas MJ, Freeston MH, Leger E, Gagnon F, Thibodeau N: Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: Evaluation in a controlled clinical trial. J Consult Clin Psychol 2000;68:957-964.
30. Öst LG, Breitholtz E: Applied relaxation vs. cognitive therapy in the treatment of generalized anxiety disorder. Behav Res Ther 2000;38:777-790.
31. Linden M (ed): Evaluative Psychotherapieforschung. Schwerpunktheft. Psychotherapie 2001;6:187-232.
32. Linden M, Zubrägel D, Achberger M, Seidel K: Psychotherapiemanual zur kognitiv-verhaltenstherapeutischen Behandlung von generalisierten Angsterkrankungen bei Patienten ohne Response auf Pharmakotherapie. Free University of Berlin, 1995, unpubl manuscript.
33. Zubrägel D, Linden, M: Generalisierte Angststörung; in Linden M, Hautzinger M (eds): Verhaltenstherapiemanual. Berlin, Springer, 2000.
34. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The validity of the Mini-International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232-241.
35. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33.
36. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959,32:50-55.
37. National Institute of Mental Health: Clinical Global Impression (German version); in Collegium Internationale Psychiatriae Scalarum (ed): Internationale Skalen für Psychiatrie. Göttingen, Beltz, 1996.
38. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA: Manual for the State-Trait Anxiety Inventory (Form Y Self-Evaluation Questionnaire). Palo Alto, Consulting Psychologists Press, 1983.
39. Linden M, Staats M, Bär T, Zubrägel D: Therapist compliance with manual guidelines in cognitive behavior therapy for generalized anxiety disorders as measured by the 'Pivotal Topic Measure'. Results from the Berlin CBT-GADStudy, submitted.
40. Linden M, Zubrägel D: Multizentrische Psychotherapiestudien in Zusammenarbeit mit niedergelassenen Psychotherapeuten. Psychotherapie 2001;6:205-210.
41. McCullagh P: Regression models for ordinal data. J R Stat Soc 1980;B42:109-142.
42. Couvée JE, Bakker A, Zitman FG: The relevance of psychiatric and somatic comorbidity in depressed chronic benzodiazepine users. Psychother Psychosom 2002;71:263-268.
43. Sharpe L, Ryan B, Allard S, Sensky T: Testing for the integrity of blinding in clinical trials: How valid are forced choice paradigms? Psychother Psychosom 2003;72:128-131.
44. Fava M, Evins AE, Dorer DJ, Schoenfeld DA: The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach. Psychother Psychosom 2003;72:115-127.
45. Linden, M, Bär T, Zubrägel D, Ahrens B, Schlattmann P: Wirksamkeit der kognitiven Verhaltenstherapie bei generalisierten Angststörungen. Ergebnisse der Berliner KVT-GADStudie. Verhaltenstherapie 2002;12:173-181.
46. Hautzinger M: Die Placebokontrollgruppe in der Psychotherapie. Psychotherapie 2001;6:199-204.